Robert Chess, Director at Twist Bioscience Corp (TWST), sold 5,000 shares at $50.00 ($250K) on 2025-01-07, disclosed to the SEC on 2025-01-10.
Scheduled sale ($250k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TWST | SELL | 2026-02-18 | $105K | — | Filing → |
| TWST | SELL | 2025-02-11 | $312K | — | Filing → |
| TWST | SELL | 2024-12-30 | $326K | — | Filing → |